These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9639420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
    Den Boer ML, Pieters R, Kazemier KM, Janka-Schaub GE, Henze G, Veerman AJ.
    Leukemia; 1999 Dec; 13(12):2023-30. PubMed ID: 10602424
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD, Wooten PJ, Sridhara R, Ordóñez JV, Lee EJ, Schiffer CA.
    Blood; 1993 Aug 15; 82(4):1288-99. PubMed ID: 8102561
    [Abstract] [Full Text] [Related]

  • 4. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR, Kelsey SM, Wu YL, Newland AC.
    Br J Haematol; 1995 Jun 15; 90(2):375-83. PubMed ID: 7794760
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD, Doyle LA, Yang W, Tong Y, Cornblatt B.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1673-83. PubMed ID: 7503771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M, Damiani D, Michelutti A, Candoni A, Masolini P, Scaggiante B, Quadrifoglio F, Baccarani M.
    Haematologica; 1994 Nov 09; 79(6):500-7. PubMed ID: 7896208
    [Abstract] [Full Text] [Related]

  • 8. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Nissen NI.
    Cancer Chemother Pharmacol; 1992 Nov 09; 30(3):235-7. PubMed ID: 1628375
    [Abstract] [Full Text] [Related]

  • 9. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M, Borg AG, Wood P, Burgess R, Fisher A, Yin JA.
    Leuk Res; 1997 Sep 09; 21(9):867-74. PubMed ID: 9393602
    [Abstract] [Full Text] [Related]

  • 10. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by a cyclosporin D analogue PSC 833].
    Dai H, Luo S, Yin A, Peng A.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan 09; 23(1):23-6. PubMed ID: 12015084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL, Guerci AP, Marchal S, Bour C, Colosetti P, Kataki A, Guerci O.
    Br J Haematol; 1998 Nov 09; 103(2):480-7. PubMed ID: 9827923
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T, Uchiyama N, Roninson IB, Cohen D, Atadja P.
    Int J Oncol; 2000 Sep 09; 17(3):579-86. PubMed ID: 10938401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ.
    Br J Cancer; 1995 Sep 09; 72(3):543-9. PubMed ID: 7669559
    [Abstract] [Full Text] [Related]

  • 17. Multidrug resistance-modifying components in human plasma with potential clinical significance.
    Mülder HS, Pinedo HM, Timmer AT, Rao BR, Lankelma J.
    J Exp Ther Oncol; 1996 Jan 09; 1(1):13-22. PubMed ID: 9414384
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.